KEAP1 and hepatocellular carcinoma: Mechanistically, PIP5K1A disrupts the binding of NRF2 and KEAP1, thereby stabilizing the NRF2 protein by reducing its ubiquitination‐mediated degradation, which in turn protects HCC cells from ferroptosis.